Dave Anderson

Dave Anderson holds the position of Senior Vice President of Portfolio Management and President of Neuromodulation at Medtronic since January 2018, overseeing therapies such as Spinal Cord Stimulation and Deep Brain Stimulation. Previously, Dave served as Vice President and General Manager of Enabling Technologies at Mozarc Medical and as Vice President of M&A Integration at Abbott, leading significant integration efforts including the acquisition of St. Jude Medical. Dave's extensive experience at St. Jude Medical includes roles such as Senior Vice President of Research and Development, managing an organization responsible for significant revenue in Cardiac Rhythm Management and Neuromodulation. Earlier career roles span several engineering and management positions at Ventritex and Advanced Cardiovascular Systems. Dave possesses an MBA from Pepperdine University, an AMP from Harvard Business School, and a BS in MSE from Kettering University.